Miraca Holdings Incorporated operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Miraca Holdings Incorporated with three other
pharmaceutical manufacturers in Asia:
Falco Holdings Co Ltd
sales of 45.96 billion Japanese Yen [US$417.33 million]
Dr. Lal PathLabs Ltd
(10.57 billion Indian Rupees [US$154.62 million]
(113.50 billion Japanese Yen [US$1.03 billion]
Miraca Holdings Incorporated reported sales of ¥195.40 billion (US$1.77 billion)
March of 2018.
decrease of 4.3%
versus 2017, when the company's sales were ¥204.25 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Miraca Holdings Incorporated had sales
of ¥192.21 billion.